Suchergebnisse - "Byrd, John"

PubPharm (111)

1

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

enthalten in: Blood | 2024

von Woyach, J. | Perez Burbano, G. | Ruppert, A. | +29

2

Zanubrutinib in Chronic Lymphocytic Leukemia

enthalten in: The New England journal of medicine | 2023

von Byrd, J. | Rothbaum, W.

CommentOn: N Engl J Med. 2023 Jan 26;388(4):319-332. - PMID 36511784

3

Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib

enthalten in: Leukemia | 2022

von Sigmund, A. | Huang, Y. | Ruppert, A. | +8

4

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies : A Phase I Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Stephens, D. | Huang, Y. | Ruppert, A. | +15

5

Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib- and acalabrutinib-treated patients

enthalten in: Blood | 2022

von Black, G. | Huang, X. | Qiao, Y. | +7

6

Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

enthalten in: Leukemia & lymphoma | 2021

von Woyach, J. | Tedeschi, A. | Munir, T. | +10

7

The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib

enthalten in: Blood | 2021

von Kittai, A. | Miller, C. | Goldstein, D. | +11

CommentIn: Blood. 2021 Dec 9;138(23):2305-2307. - PMID 34882215

8

Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition

enthalten in: Cancer research communications | 2021

von Eisenmann, E. | Fu, Q. | Muhowski, E. | +8

9

Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients

enthalten in: Leukemia | 2021

von Miller, C. | Huang, Y. | Ruppert, A. | +13

10

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia : Results of the First Randomized Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Byrd, J. | Hillmen, P. | Ghia, P. | +21

CommentIn: J Clin Oncol. 2021 Nov 1;39(31):3419-3422. - PMID 34310198

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]